Roche Holding AG (OTCQX International Premier:RHHBF)

345.00
Delayed Data
As of Aug 11
 +1.75 / +0.51%
Today’s Change
265.10
Today|||52-Week Range
375.01
+8.95%
Year-to-Date
The Danaher Juggernaut Rolls On, Crushing Valuation Concerns Under The Wheels Of Growth
Jul 31 / Seeking Alpha - Paid Partner Content
UCB out-licenses Alzheimer's candidate to Roche
Jul 29 / Seeking Alpha - Paid Partner Content
Checkmate Pharmaceuticals Begins IPO Process
Jul 31 / Seeking Alpha - Paid Partner Content
Roche comes up empty in study of Actemra in COVID-19
Jul 29 / Seeking Alpha - Paid Partner Content
FDA OKs Roche triplet therapy for certain type of melanoma
Jul 31 / Seeking Alpha - Paid Partner Content
Wide-Moat Stocks On Sale - The August 2020 Heat Map
Jul 27 / Seeking Alpha - Paid Partner Content
FDA OKs Roche Herceptin companion diagnostic
Jul 29 / Seeking Alpha - Paid Partner Content
Compugen: Clinical Data Supports COM701 As A Potential Breakthrough Cancer Treatment
Jul 27 / Seeking Alpha - Paid Partner Content
New Herceptin biosimilar OK'd in Europe
Jul 29 / Seeking Alpha - Paid Partner Content
Mid-stage study underway on Immunic's IMU-838 in COVID-19
Jul 27 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close343.25
Today’s open344.50
Day’s range340.00 - 345.00
Volume411
Average volume (3 months)402
Market cap$55.2B
Data as of 08/11/2020

Growth & Valuation

Earnings growth (last year)+26.29%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+6.48%
P/E ratio--
Price/Sales4.44
Price/Book8.74

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$61.9B
Annual profit (last year)$13.6B
Net profit margin21.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Chart unavailable